Led by Scientists at Banner Alzheimer's Institute, Test of Alzheimer’s Drug Gets Large Federal $33.2 Million Grant

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In the most significant sign yet of a broad shift in the focus of Alzheimer’s research from treating to preventing the disease, the federal government announced on Wednesday its largest grant so far to test an Alzheimer’s drug on healthy people at greatest risk for the most common form of the disease. The $33.2 million grant, and several other prevention studies awarded federal money in the last year, follow years of unsuccessful trials of treatments on people who already have dementia. Those failures have led to the realization that these drugs appear to be ineffective by the time memory and thinking problems have taken hold.

Help employers find you! Check out all the jobs and post your resume.

Back to news